These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 139314)

  • 1. Inhibition of human mixed lymphocyte culture stimulation by anti-HLA-D-associated antisera: studies with primed responding cells.
    Hirschberg H; Albrechtsen D; Solheim BG; Thorsby E
    Eur J Immunol; 1977 Jan; 7(1):26-9. PubMed ID: 139314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of lymphocytes by allogeneic lymphocytes and lymphoblasts in the presence of anti-HLA antisera.
    Corley RB; Dawson JR; Amos DB
    Eur J Immunol; 1976 Apr; 6(4):235-40. PubMed ID: 186270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close association between Fc receptor and HLA-D-associated (Ia-like) determinants on human lymphoid cells.
    Solheim BG; Thorsby E; Möller E
    Transplant Proc; 1977 Mar; 9(1):1219-21. PubMed ID: 68569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Ia-like DRw lymphocyte antigens stimulating activity in primary mixed lymphocyte reaction.
    Fradelizi D; Nunez-Roldan A; Sasportes M
    Eur J Immunol; 1978 Feb; 8(2):88-93. PubMed ID: 77783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of human lymphocyte responses by primed autologous lymphocytes. I. Evaluation of MLR inhibition as a model for suppression.
    Sheehy MJ; Mawas C; Charmot D
    J Immunol; 1979 Jun; 122(6):2198-203. PubMed ID: 87456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions.
    Nieda M; Juji T; Imao S
    J Clin Invest; 1985 Oct; 76(4):1477-84. PubMed ID: 2932467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of HLA--D associated B lymphocyte (Ia-like) antigens in the cell membrane.
    Albrechtsen D; Solheim BG; Thorsby E
    Tissue Antigens; 1978 Apr; 11(4):372-83. PubMed ID: 78538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immune responses to hapten-conjugated cells. II. The roles of autologous and allogeneic histocompatibility determinants in proliferative responses in vitro.
    Seldin MF; Rich RR; Dupont B
    J Immunol; 1979 May; 122(5):1828-33. PubMed ID: 87444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Ia-like antigens associated with HLA-d.
    Albrechtsen D; Solheim BG; Thorsby E
    Scand J Immunol; 1977; 6(5):419-25. PubMed ID: 70059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA factors and immune function.
    Svejgaard A
    Acta Endocrinol Suppl (Copenh); 1976; 205():77-84. PubMed ID: 63212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human alloantiserum precipitates Ia-like molecules from chronic lymphocytic leukemia cells.
    Nilsson S; Schwartz BD; Waxdal M; Green E; Cullen SE; Mann DL
    J Immunol; 1977 Apr; 118(4):1271-4. PubMed ID: 66283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typing for HLA-D: primed LD typing and homozygous typing cells.
    Bach FH; Valentine EA; Alter BJ; Svejgaard A; Thomsen M
    Tissue Antigens; 1976 Aug; 8(2):151-5. PubMed ID: 135377
    [No Abstract]   [Full Text] [Related]  

  • 16. Primed lymphocyte typing in the assay of HLA-D region disparity.
    Bach ML; Jarrett-Toth E; Benike C; Shih CY; Valentine E; Alter BJ; Bach FH
    Transplant Proc; 1977 Mar; 9(1):405-9. PubMed ID: 141130
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of HL-A antigens by anti-HLA antiserum: effects on the cytotoxicity assay and mixed leukocyte reaction.
    Sadeghee S; Hebert J; Kelley J; Abdou NI
    J Immunol; 1975 Sep; 115(3):811-6. PubMed ID: 125303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
    Engleman EG; McDevitt HO
    J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.
    Halper JP; Fu SM; Gottlieb AB; Winchester RJ; Kunkel HG
    J Clin Invest; 1979 Nov; 64(5):1141-8. PubMed ID: 159311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.